Homeodomain-interacting protein kinase 2-dependent repression of myogenic differentiation is relieved by its caspase-mediated cleavage

Nucleic Acids Research

Volumn 41, Issue 11, 2013, Pages 5731-5745

  De La Vega, Laureano ^a   Hornung, Juliane ^a   Kremmer, Elisabeth ^b   Milanovic, Maja ^a   Lienhard Schmitz, M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; CASPASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 4; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; MYOCYTE ENHANCER FACTOR 2; SHORT HAIRPIN RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

ACETYLATION; ANIMALS; ASPARTIC ACID; CARRIER PROTEINS; CASPASES; CELL DIFFERENTIATION; CELL LINE; CO-REPRESSOR PROTEINS; HISTONE DEACETYLASES; HUMANS; MICE; MUSCLE DEVELOPMENT; MYOBLASTS, SKELETAL; MYOGENIC REGULATORY FACTORS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC;

EID: 84878870624     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt262     Document Type: Article

References (71)

1. Isono, K., Nemoto, K., Li, Y., Takada, Y., Suzuki, R., Katsuki, M., Nakagawara, A. and Koseki, H. (2006) Overlapping roles for homeodomain- interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol. Cell. Biol., 26, 2758-2771.
2. Aikawa, Y., Nguyen, L.A., Isono, K., Takakura, N., Tagata, Y., Schmitz, M.L., Koseki, H. and Kitabayashi, I. (2006) Roles of HIPK1 and HIPK2 in AML1-and p300-dependent transcription, hematopoiesis and blood vessel formation. EMBO J., 25, 3955-3965.
3. Saul, V.V., de la Vega, L., Milanovic, M., Krü ger, M., Braun, T., Fritz-Wolf, K., Becker, K. and Schmitz, M.L. (2013) HIPK2 kinase activity depends on cis-autophosphorylation of its activation loop. J. Mol. Cell Biol., 5, 27-38.
4. Calzado, M.A., de la Vega, L., Moller, A., Bowtell, D.D. and Schmitz, M.L. (2009) An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response. Nat. Cell Biol., 11, 85-91.
5. Choi, D.W., Seo, Y.M., Kim, E.A., Sung, K.S., Ahn, J.W., Park, S.J., Lee, S.R. and Choi, C.Y. (2008) Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J. Biol. Chem., 283, 4682-4689.
6. Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F. and Soddu, S. (2007) MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damageinduced apoptosis. Mol. Cell, 25, 739-750.
7. Shima, Y., Shima, T., Chiba, T., Irimura, T., Pandolfi, P.P. and Kitabayashi, I. (2008) PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation. Mol. Cell Biol., 28, 7126-7138.
8. Gresko, E., Roscic, A., Ritterhoff, S., Vichalkovski, A., del Sal, G. and Schmitz, M.L. (2006) Autoregulatory control of the p53 response by caspase-mediated processing of HIPK2. EMBO J., 25, 1883-1894.
9. Choi, C.Y., Kim, Y.H., Kim, Y.O., Park, S.J., Kim, E.A., Riemenschneider, W., Gajewski, K., Schulz, R.A. and Kim, Y. (2005) Phosphorylation by the DHIPK2 protein kinase modulates the corepressor activity of Groucho. J. Biol. Chem., 280, 21427-21436.
10. Lee, W., Andrews, B.C., Faust, M., Walldorf, U. and Verheyen, E.M. (2009) Hipk is an essential protein that promotes Notch signal transduction in the Drosophila eye by inhibition of the global co-repressor Groucho. Dev. Biol., 325, 263-272.
11. Inoue, T., Kagawa, T., Inoue-Mochita, M., Isono, K., Ohtsu, N., Nobuhisa, I., Fukushima, M., Tanihara, H. and Taga, T. (2010) Involvement of the Hipk family in regulation of eyeball size, lens formation and retinal morphogenesis. FEBS Lett., 584, 3233-3238.
12. Chalazonitis, A., Tang, A.A., Shang, Y., Pham, T.D., Hsieh, I., Setlik, W., Gershon, M.D. and Huang, E.J. (2011) Homeodomain interacting protein kinase 2 regulates postnatal development of enteric dopaminergic neurons and glia via BMP signaling. J. Neurosci., 31, 13746-13757.
13. Hattangadi, S.M., Burke, K.A. and Lodish, H.F. (2010) Homeodomain-interacting protein kinase 2 plays an important role in normal terminal erythroid differentiation. Blood, 115, 4853-4861.
14. Ohtsu, N., Nobuhisa, I., Mochita, M. and Taga, T. (2007) Inhibitory effects of homeodomain-interacting protein kinase 2 on the aorta-gonad- mesonephros hematopoiesis. Exp. Cell Res., 313, 88-97.
15. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G. et al. (2002) Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat. Cell Biol., 4, 11-19.
16. Hofmann, T.G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H. and Schmitz, M.L. (2002) Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat. Cell Biol., 4, 1-10.
17. Hikasa, H. and Sokol, S.Y. (2011) Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. J. Biol. Chem., 286, 12093-12100.
18. Hailemariam, K., Iwasaki, K., Huang, B.W., Sakamoto, K. and Tsuji, Y. (2010) Transcriptional regulation of ferritin and antioxidant genes by HIPK2 under genotoxic stress. J. Cell Sci., 123, 3863-3871.
19. Bracaglia, G., Conca, B., Bergo, A., Rusconi, L., Zhou, Z., Greenberg, M.E., Landsberger, N., Soddu, S. and Kilstrup-Nielsen, C. (2009) Methyl-CpG-binding protein 2 is phosphorylated by homeodomain-interacting protein kinase 2 and contributes to apoptosis. EMBO Rep., 10, 1327-1333.
20. Yamada, D., Perez-Torrado, R., Filion, G., Caly, M., Jammart, B., Devignot, V., Sasai, N., Ravassard, P., Mallet, J., Sastre-Garau, X. et al. (2009) The human protein kinase HIPK2 phosphorylates and downregulates the methyl-binding transcription factor ZBTB4. Oncogene, 28, 2535-2544.
21. Roscic, A., Moller, A., Calzado, M.A., Renner, F., Wimmer, V.C., Gresko, E., Ludi, K.S. and Schmitz, M.L. (2006) Phosphorylationdependent control of Pc2 SUMO E3 ligase activity by its substrate protein HIPK2. Mol. Cell, 24, 77-89.
22. Choi, C.Y., Kim, Y.H., Kwon, H.J. and Kim, Y. (1999) The homeodomain protein NK-3 recruits Groucho and a histone deacetylase complex to repress transcription. J. Biol. Chem., 274, 33194-33197.
23. de la Vega, L., Grishina, I., Moreno, R., Kruger, M., Braun, T. and Schmitz, M.L. (2012) A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol. Cell, 46, 472-483.
24. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S. and van Kuilenburg, A.B. (2003) Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J., 370, 737-749.
25. Guenther, M.G., Lane, W.S., Fischle, W., Verdin, E., Lazar, M.A. and Shiekhattar, R. (2000) A core SMRT corepressor complex containing HDAC3 and TBL1, a WD40-repeat protein linked to deafness. Genes Dev., 14, 1048-1057.
26. Li, J., Wang, J., Nawaz, Z., Liu, J.M., Qin, J. and Wong, J. (2000) Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J., 19, 4342-4350.
27. Ago, T., Liu, T., Zhai, P., Chen, W., Li, H., Molkentin, J.D., Vatner, S.F. and Sadoshima, J. (2008) A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell, 133, 978-993.
28. Paroni, G., Mizzau, M., Henderson, C., Del Sal, G., Schneider, C. and Brancolini, C. (2004) Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell, 15, 2804-2818.
29. Bertos, N.R., Wang, A.H. and Yang, X.J. (2001) Class II histone deacetylases: structure, function, and regulation. Biochem. Cell Biol., 79, 243-252.
30. Lu, J., McKinsey, T.A., Zhang, C.L. and Olson, E.N. (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell, 6, 233-244.
31. McKinsey, T.A., Zhang, C.L., Lu, J. and Olson, E.N. (2000) Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature, 408, 106-111.
32. Bennett, A.M. and Tonks, N.K. (1997) Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science, 278, 1288-1291.
33. Tapscott, S.J. (2005) The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development, 132, 2685-2695.
34. Naya, F.J. and Olson, E. (1999) MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol., 11, 683-688.
35. Miska, E.A., Karlsson, C., Langley, E., Nielsen, S.J., Pines, J. and Kouzarides, T. (1999) HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J., 18, 5099-5107.
36. Mal, A. and Harter, M.L. (2003) MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc. Natl Acad. Sci. USA, 100, 1735-1739.
37. Gregoire, S., Xiao, L., Nie, J., Zhang, X., Xu, M., Li, J., Wong, J., Seto, E. and Yang, X.J. (2007) Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol., 27, 1280-1295.
38. Nebbioso, A., Manzo, F., Miceli, M., Conte, M., Manente, L., Baldi, A., De Luca, A., Rotili, D., Valente, S., Mai, A. et al. (2009) Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes. EMBO Rep., 10, 776-782.
39. Zhao, X., Sternsdorf, T., Bolger, T.A., Evans, R.M. and Yao, T.P. (2005) Regulation of MEF2 by histone deacetylase 4-and SIRT1 deacetylase-mediated lysine modifications. Mol. Cell. Biol., 25, 8456-8464.
40. Gregoire, S. and Yang, X.J. (2005) Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors. Mol. Cell. Biol., 25, 2273-2287.
41. Chin, E.R., Olson, E.N., Richardson, J.A., Yang, Q., Humphries, C., Shelton, J.M., Wu, H., Zhu, W., Bassel-Duby, R. and Williams, R.S. (1998) A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev., 12, 2499-2509.
42. Gregoire, S., Tremblay, A.M., Xiao, L., Yang, Q., Ma, K., Nie, J., Mao, Z., Wu, Z., Giguere, V. and Yang, X.J. (2006) Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem., 281, 4423-4433.
43. Ehrhardt, C., Schmolke, M., Matzke, A., Knoblauch, A., Will, C., Wixler, V. and Ludwig, S. (2006) Polyethylenimine, a cost-effective transfection reagent. Signal Transduct., 6, 179-184.
44. Renner, F., Saul, V.V., Pagenstecher, A., Wittwer, T. and Schmitz, M.L. (2011) Inducible SUMO modification of TANK alleviates its repression of TLR7 signalling. EMBO Rep., 12, 129-135.
45. Moreno, R., Sobotzik, J.M., Schultz, C. and Schmitz, M.L. (2010) Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res., 38, 6029-6044.
46. Pierantoni, G.M., Bulfone, A., Pentimalli, F., Fedele, M., Iuliano, R., Santoro, M., Chiariotti, L., Ballabio, A. and Fusco, A. (2002) The homeodomain-interacting protein kinase 2 gene is expressed late in embryogenesis and preferentially in retina, muscle, and neural tissues. Biochem. Biophys. Res. Commun., 290, 942-947.
47. Yaffe, D. and Saxel, O. (1977) Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature, 270, 725-727.
48. Iacovelli, S., Ciuffini, L., Lazzari, C., Bracaglia, G., Rinaldo, C., Prodosmo, A., Bartolazzi, A., Sacchi, A. and Soddu, S. (2009) HIPK2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif., 42, 373-384.
49. Doxakis, E., Huang, E.J. and Davies, A.M. (2004) Homeodomaininteracting protein kinase-2 regulates apoptosis in developing sensory and sympathetic neurons. Curr. Biol., 14, 1761-1765.
50. Kuranaga, E. and Miura, M. (2007) Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol., 17, 135-144.
51. Fernando, P., Kelly, J.F., Balazsi, K., Slack, R.S. and Megeney, L.A. (2002) Caspase 3 activity is required for skeletal muscle differentiation. Proc. Natl Acad. Sci. USA, 99, 11025-11030.
52. Wang, X.H., Zhang, L., Mitch, W.E., LeDoux, J.M., Hu, J. and Du, J. (2010) Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J. Biol. Chem., 285, 21249-21257.
53. Gordon, J.W., Pagiatakis, C., Salma, J., Du, M., Andreucci, J.J., Zhao, J., Hou, G., Perry, R.L., Dan, Q., Courtman, D. et al. (2009) Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J. Biol. Chem., 284, 19027-19042.
54. Zhou, X., Richon, V.M., Wang, A.H., Yang, X.J., Rifkind, R.A. and Marks, P.A. (2000) Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic Ras. Proc. Natl Acad. Sci. USA, 97, 14329-14333.
55. Puri, P.L., Bhakta, K., Wood, L.D., Costanzo, A., Zhu, J. and Wang, J.Y. (2002) A myogenic differentiation checkpoint activated by genotoxic stress. Nat. Genet., 32, 585-593.
56. Soddu, S., Blandino, G., Scardigli, R., Coen, S., Marchetti, A., Rizzo, M.G., Bossi, G., Cimino, L., Crescenzi, M. and Sacchi, A. (1996) Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol., 134, 193-204.
57. Rinaldo, C., Prodosmo, A., Siepi, F. and Soddu, S. (2007) HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem. Cell Biol., 85, 411-418.
58. Tapscott, S.J., Davis, R.L., Thayer, M.J., Cheng, P.F., Weintraub, H. and Lassar, A.B. (1988) MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science, 242, 405-411.
59. Harada, J., Kokura, K., Kanei-Ishii, C., Nomura, T., Khan, M.M., Kim, Y. and Ishii, S. (2003) Requirement of the co-repressor homeodomain-interacting protein kinase 2 for ski-mediated inhibition of bone morphogenetic protein-induced transcriptional activation. J. Biol. Chem., 278, 38998-39005.
60. Katagiri, T., Akiyama, S., Namiki, M., Komaki, M., Yamaguchi, A., Rosen, V., Wozney, J.M., Fujisawa-Sehara, A. and Suda, T. (1997) Bone morphogenetic protein-2 inhibits terminal differentiation of myogenic cells by suppressing the transcriptional activity of MyoD and myogenin. Exp. Cell Res., 230, 342-351.
61. Massague, J., Cheifetz, S., Endo, T. and Nadal-Ginard, B. (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc. Natl Acad. Sci. USA, 83, 8206-8210.
62. Ma, K., Chan, J.K., Zhu, G. and Wu, Z. (2005) Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol. Cell. Biol., 25, 3575-3582.
63. Al Madhoun, A.S., Mehta, V., Li, G., Figeys, D., Wiper-Bergeron, N. and Skerjanc, I.S. (2011) Skeletal myosin light chain kinase regulates skeletal myogenesis by phosphorylation of MEF2C. EMBO J., 30, 2477-2489.
64. Magli, A., Angelelli, C., Ganassi, M., Baruffaldi, F., Matafora, V., Battini, R., Bachi, A., Messina, G., Rustighi, A., Del Sal, G. et al. (2010) Proline isomerase Pin1 represses terminal differentiation and myocyte enhancer factor 2C function in skeletal muscle cells. J. Biol. Chem., 285, 34518-34527.
65. Wang, A.H., Kruhlak, M.J., Wu, J., Bertos, N.R., Vezmar, M., Posner, B.I., Bazett-Jones, D.P. and Yang, X.J. (2000) Regulation of histone deacetylase 4 by binding of 14-3-3 proteins. Mol. Cell. Biol., 20, 6904-6912.
66. Gresko, E., Moller, A., Roscic, A. and Schmitz, M.L. (2005) Covalent modification of human homeodomain interacting protein kinase 2 by SUMO-1 at lysine 25 affects its stability. Biochem. Biophys. Res. Commun., 329, 1293-1299.
67. Kirsh, O., Seeler, J.S., Pichler, A., Gast, A., Muller, S., Miska, E., Mathieu, M., Harel-Bellan, A., Kouzarides, T., Melchior, F. et al. (2002) The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J., 21, 2682-2691.
68. de la Vega, L., Frobius, K., Moreno, R., Calzado, M.A., Geng, H. and Schmitz, M.L. (2011) Control of nuclear HIPK2 localization and function by a SUMO interaction motif. Biochim. Biophys. Acta, 1813, 283-297.
69. Sung, K.S., Lee, Y.A., Kim, E.T., Lee, S.R., Ahn, J.H. and Choi, C.Y. (2011) Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Exp. Cell Res., 317, 1060-1070.
70. Shen, T.H., Lin, H.K., Scaglioni, P.P., Yung, T.M. and Pandolfi, P.P. (2006) The mechanisms of PML-nuclear body formation. Mol. Cell, 24, 331-339.
71. Fischle, W., Dequiedt, F., Hendzel, M.J., Guenther, M.G., Lazar, M.A., Voelter, W. and Verdin, E. (2002) Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell, 9, 45-57.